Baseline Predictors of Clinical Response: A Post Hoc Analysis of the Ambition Trial

被引：0
|
作者：
Benza, Raymond [1 ]
Blair, Christiana [1 ]
Patel, Krishna [1 ]
Eads, Michael [1 ]
机构：
[1] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
来源：
CHEST | 2017年 / 152卷 / 04期
关键词：
D O I：
10.1016/j.chest.2017.08.1085
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1052A / 1052A
页数：1
相关论文
共 50 条
  • [1] Predictors of Nail Response with Guselkumab: A Post Hoc Analysis of the VOYAGE 2 Clinical Trial
    Egeberg, Alexander
    Tillett, William
    Sonkoly, Eniko
    Gorecki, Patricia
    Tjarnlund, Anna
    Buyze, Jozefien
    Wegner, Sven
    McGonagle, Dennis
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2008 - 2011
  • [2] Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial
    Kivitz, Alan
    Sedova, Liliana
    Churchill, Melvin
    Vizcaya, Cynthia
    Sutariya, Reema
    Cao, Wenhao
    Singhal, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4750 - 4752
  • [3] Predictors of Clinical Response to Intravenous Secukinumab Among Patients with Axial Spondyloarthritis: A Post Hoc Analysis of a Phase 3 Trial
    Deodhar, Atul
    Dokoupilova, Eva
    Vizcaya, Cynthia
    Sutariya, Reema
    Bao, Weibin
    Kapur, Karen
    Rohrer, Susanne
    Kivitz, Alan
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3020 - 3023
  • [4] Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
    Tsujii, Takashi
    Sakurai, Hitoshi
    Takeuchi, Hiroyoshi
    Suzuki, Takefumi
    Mimura, Masaru
    Uchida, Hiroyuki
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2022, 42 (04) : 516 - 520
  • [5] Baseline cholesterol absorption and the response to ezetimibe/simvastatin therapy: a post-hoc analysis of the ENHANCE trial
    Jakulj, L.
    Vissers, M. N.
    Groen, A. K.
    Hutten, B. A.
    Lutjohann, D.
    Veltri, E. P.
    Kastelein, J. J. P.
    JOURNAL OF LIPID RESEARCH, 2010, 51 (04) : 755 - 762
  • [6] Post hoc subgroup analysis and the truth of a clinical trial
    Adams, KF
    AMERICAN HEART JOURNAL, 1998, 136 (05) : 753 - 758
  • [7] Hepatic safety of ambrisentan alone and in combination with tadalafil: a post-hoc analysis of the AMBITION trial
    Patel, Krishna R.
    Blair, Christiana J.
    Tislow, James D.
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [8] Response to: 'baseline differences in SAVOR trial' - prespecified vs. post hoc analysis - a potential source of bias
    Raz, I.
    Cahn, A.
    Mosenzon, O.
    Scirica, B. M.
    Bhatt, D. L.
    DIABETES OBESITY & METABOLISM, 2015, 17 (12): : 1203 - 1204
  • [9] Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
    Fleischmann, Roy
    Hayes, Kyle
    Ahn, Sung-Woo
    Wan, George J.
    Panaccio, Mary
    Karlsson, Daniel
    Furst, Daniel E.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 649 - 661
  • [10] Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
    Roy Fleischmann
    Kyle Hayes
    Sung-Woo Ahn
    George J. Wan
    Mary Panaccio
    Daniel Karlsson
    Daniel E. Furst
    Rheumatology and Therapy, 2022, 9 : 649 - 661
12345